CNS pipeline · person
Jane Ryan, PhD
Non-Executive Director of Neuphoria Therapeutics (formerly Bionomics) since October 2020; a member of the Audit and Risk Management Committee and Chair of the Nomination and Compensation Committee. She provides executive advisory services to biotechnology companies and previously was CEO of Sementis and a product-development division leader at Biota. She received her B.Sc. from the Australian National University, her Ph.D. from Macquarie University, and was a postdoctoral fellow at Columbia University.
- 1 company
Courtesy Neuphoria Therapeutics
Current roles
- Neuphoria Therapeutics, Inc.Non-Executive Director · Board2020–present
Appears with
People sharing a company with Jane.
- Alan Fisher · Neuphoria Therapeutics, Inc.
- David Wilson · Neuphoria Therapeutics, Inc.
- Liz Doolin · Neuphoria Therapeutics, Inc.
- Peter Miles Davies · Neuphoria Therapeutics, Inc.
- Spyridon "Spyros" Papapetropoulos · Neuphoria Therapeutics, Inc.
- Tim Cunningham · Neuphoria Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.